Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 29 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-0.59 Insider Own0.34% Shs Outstand54.15M Perf Week-0.12%
Market Cap3.27B Forward P/E17.96 EPS next Y3.37 Insider Trans0.00% Shs Float53.97M Perf Month7.66%
Income-31.82M PEG- EPS next Q0.79 Inst Own108.36% Short Float5.07% Perf Quarter9.77%
Sales1.18B P/S2.77 EPS this Y9.72% Inst Trans1.43% Short Ratio3.85 Perf Half Y31.89%
Book/sh22.56 P/B2.68 EPS next Y9.58% ROA-1.34% Short Interest2.74M Perf Year37.37%
Cash/sh11.37 P/C5.32 EPS next 5Y-4.60% ROE-2.60% 52W Range42.75 - 64.47 Perf YTD16.87%
Dividend Est.- P/FCF107.57 EPS past 5Y- ROI-1.70% 52W High-6.21% Beta0.99
Dividend TTM- Quick Ratio2.71 Sales past 5Y1.30% Gross Margin68.83% 52W Low41.45% ATR (14)1.50
Dividend Ex-Date- Current Ratio3.17 EPS Y/Y TTM61.47% Oper. Margin10.37% RSI (14)53.81 Volatility2.15% 2.67%
Employees2900 Debt/Eq0.55 Sales Y/Y TTM13.03% Profit Margin-2.69% Recom1.80 Target Price71.00
Option/ShortYes / Yes LT Debt/Eq0.53 EPS Q/Q-668.11% Payout0.00% Rel Volume0.47 Prev Close60.04
Sales Surprise4.54% EPS Surprise50.11% Sales Q/Q10.51% EarningsMay 01 BMO Avg Volume710.29K Price60.47
SMA20-1.65% SMA505.75% SMA20014.98% Trades Volume331,605 Change0.72%
Date Action Analyst Rating Change Price Target Change
Mar-20-24Reiterated Needham Buy
Feb-20-24Upgrade Mizuho Neutral → Buy $60 → $70
Sep-06-23Initiated HSBC Securities Hold $52
Jul-19-23Initiated Robert W. Baird Neutral $56
Apr-14-23Initiated Mizuho Neutral $48
Dec-21-22Initiated Barclays Equal Weight $62
Apr-06-22Initiated Wolfe Research Outperform $95
Feb-24-22Upgrade UBS Neutral → Buy $96
Dec-03-21Initiated Goldman Buy $108
Aug-20-21Reiterated Needham Buy $104 → $117
May-23-24 09:00AM
May-02-24 11:50AM
May-01-24 08:12PM
07:10AM Loading…
Apr-30-24 09:00AM
Apr-26-24 12:34PM
Apr-25-24 04:03PM
Apr-24-24 10:01AM
Mar-21-24 09:00AM
09:00AM Loading…
Mar-20-24 09:00AM
Mar-05-24 09:55PM
Mar-04-24 04:44PM
Feb-22-24 09:58AM
Feb-21-24 03:15PM
Feb-13-24 01:04PM
Feb-09-24 04:34AM
Feb-06-24 06:15AM
Feb-05-24 08:00AM
Jan-10-24 05:00AM
08:30AM Loading…
Jan-08-24 08:30AM
Jan-04-24 09:00AM
Dec-12-23 08:02PM
Dec-05-23 09:39AM
Nov-27-23 06:04AM
Nov-24-23 02:19PM
Nov-22-23 07:55PM
Nov-09-23 09:00AM
Nov-02-23 02:48PM
Nov-01-23 09:36AM
Oct-25-23 09:00AM
Oct-06-23 08:30AM
Sep-25-23 06:01PM
Sep-21-23 07:00AM
Sep-20-23 09:00AM
Sep-05-23 09:46AM
Aug-30-23 04:05PM
Aug-24-23 09:00AM
Jul-26-23 05:21PM
Jul-03-23 03:11PM
Jun-21-23 08:00PM
Jun-17-23 10:20AM
Jun-14-23 09:00AM
Jun-13-23 09:00AM
May-29-23 11:53AM
May-18-23 07:17AM
May-08-23 09:51AM
May-03-23 07:25AM
Apr-26-23 08:00PM
Apr-20-23 08:29AM
Apr-18-23 08:26AM
Apr-17-23 05:07PM
Apr-14-23 04:30PM
Apr-13-23 06:14AM
Apr-06-23 06:21PM
Mar-31-23 10:36AM
Mar-22-23 09:00AM
Mar-15-23 09:55AM
Mar-09-23 04:05PM
Mar-02-23 07:36AM
Mar-01-23 09:22AM
Feb-28-23 10:05AM
Feb-23-23 05:50AM
Feb-22-23 06:33PM
Feb-08-23 05:06PM
Feb-03-23 11:20AM
Jan-27-23 12:55PM
Jan-18-23 09:00AM
Jan-10-23 09:15AM
Jan-07-23 09:16AM
Dec-15-22 08:58AM
Dec-13-22 04:05PM
Nov-30-22 09:00AM
Nov-24-22 05:34AM
Nov-17-22 09:00AM
Nov-08-22 09:00AM
LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. It operates through the following segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support (ACS). The Cardiopulmonary segment is involved in the design, development, manufacture, marketing and selling of cardiopulmonary products. The Neuromodulation segment is associated in the design, development, manufacture, marketing and selling of devices that deliver neuromodulation therapy for treating DRE and DTD. The ACS segment deals with the design, development, manufacture, marketing and selling of temporary life support products. The company was founded in 1987 and is headquartered in London, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bolton StephaniePresident, Global EpilepsyMar 30 '24Option Exercise0.007,744013,205Apr 02 09:22 PM
Hebbelinck TruiChief Human Resources OfficerMar 30 '24Option Exercise0.0011,779019,320Apr 02 09:21 PM
Shvartsburg AlexCFOMar 30 '24Option Exercise0.0014,752024,133Apr 02 09:20 PM
Hutchinson Michael DamonChief Legal OfficerMar 30 '24Option Exercise0.001,47802,828Apr 02 09:18 PM
KOZY WILLIAM AChairman and CEOFeb 29 '24Option Exercise0.0014,512032,333Mar 04 05:22 PM
Saia Andrea LynnDirectorDec 31 '23Option Exercise0.001,468011,113Jan 03 04:14 PM
Hutchinson Michael DamonChief Legal OfficerDec 15 '23Option Exercise0.002,25402,254Dec 19 04:28 PM
Shvartsburg AlexCFODec 15 '23Option Exercise0.0061309,548Dec 19 04:16 PM
KOZY WILLIAM ADirectorOct 14 '23Option Exercise0.0010,311021,550Oct 17 08:01 PM
Story BrookeDirectorSep 15 '23Option Exercise0.001,72501,725Sep 19 05:08 PM
Hebbelinck TruiChief Human Resources OfficerSep 15 '23Option Exercise0.0044007,748Sep 19 04:58 PM
WILVER PETER MDirectorJun 15 '23Option Exercise0.002,08202,082Jun 20 03:36 PM
SCHERMERHORN TODD CDirectorJun 15 '23Option Exercise0.002,08204,416Jun 20 03:32 PM
Shvartsburg AlexCFOJun 15 '23Option Exercise0.001,57709,677Jun 20 03:39 PM
KOZY WILLIAM ADirectorJun 15 '23Option Exercise0.003,284011,754Jun 20 03:38 PM
Moore Daniel JeffreyDirectorJun 15 '23Option Exercise0.002,082027,978Jun 20 03:20 PM
Enxing Seng StacyDirectorJun 15 '23Option Exercise0.002,08207,095Jun 20 03:13 PM
Bianchi FrancescoDirectorJun 15 '23Option Exercise0.002,08208,622Jun 20 03:10 PM
Saia Andrea LynnDirectorJun 15 '23Option Exercise0.002,082010,090Jun 20 03:28 PM
O'Kane SharonDirectorJun 15 '23Option Exercise0.002,08209,053Jun 20 03:24 PM